Clinical trial of ABC294640 in patients with refractory multiple myeloma
Ended Cooperative Agreement Awarded Last action
- Award ID
- R44CA199767
- Recipient
-
Apogee Biotechnology Corporation UEI J9Q4KEGSLWY9
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $1,979,746
Award facts
- Assistance listing
- 93.395 Cancer Treatment Research
- Completion date
- Originally
- Place of performance
- Hummelstown, PA 17036, USA
Award details come from USAspending.gov.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $0 | |
| Amendment | $653,219 | |
| Amendment | $659,861 | |
| Original award | $666,666 |
Quick answers
Who received award R44CA199767?
R44CA199767 was awarded to Apogee Biotechnology Corporation by National Cancer Institute (National Institutes of Health) on September 1, 2015.
How much is award R44CA199767 worth?
$1,979,746 has been obligated on R44CA199767.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award